AMAM

Ambrx Biopharma Inc
AMAM

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AMAM was delisted on the 6th of March, 2024.

Back to rankings

20 hedge funds and large institutions have $266M invested in Ambrx Biopharma Inc in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$68.7M
2
+$47M
3
+$37.9M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$35.8M
5
SCM
Suvretta Capital Management
New York
+$22.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$68.7M
2
$47M
3
$37.9M
4
$35.8M
5
$22.9M
6
$16.7M
7
$16.7M
8
$8.82M
9
$2.82M
10
$2.16M
11
$1.37M
12
$1.37M
13
$1.18M
14
$784K
15
$784K
16
$640K
17
$294K
18
$263K
19
$20K
20
$2K